brenzavvy
(Bexagliflozin)TheracosBio, LLC
Usage: BRENZAVVY is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It is not recommended for patients with type 1 diabetes mellitus.
Sodium-Glucose Cotransporter 2 Inhibitor class drugs
3 results
farxiga
(DAPAGLIFLOZIN)AstraZeneca Pharmaceuticals LPUsage: FARXIGA (dapagliflozin) is indicated for reducing risks associated with chronic kidney disease, heart failure, and for improving glycemic control in adults and pediatric patients (10 years and older) with type 2 diabetes mellitus, alongside diet and exercise. It is not recommended for type 1 diabetes or specific kidney conditions.inpefa
(sotagliflozin)Lexicon Pharmaceuticals, Inc.Usage: INPEFA is indicated for reducing the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure or type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors.